Recent Finacing
Recent Raise
Galecto is a Boston-based clinical-stage biopharmaceutical company developing novel small-molecule and antibody therapies for blood cancers, cancer and liver diseases.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
